however, this phenomenon is blunted in in the diabetic state (Figure 1)
Second, it is important to acknowledge that the risk of bias assessment indicated moderate to high risk in several studies
In vitro models often measure changes in cytokine expression profiles, oxidative stress indicators, and regulatory signaling proteins following exposure to copper-peptide complexes
Therefore, the attenuation of methylglyoxal-induced mitochondrial abnormalities may suppress the progression of heart failure
Al-SadawiMAslamFAleemSAlsadaoeeMStevensGASinghAet alAssociation of glp-1 agonists with arrhythmias and sudden cardiac death in patients with type 2 diabetes: a meta-analysis of 27 randomized controlled trials
Clinical evidence: key trials and outcomes GLP-1 receptor agonists have shown kidney benefits in cardiovascular safety trials, primarily by reducing the onset and progression of albuminuria [62]